Data / Form D filings / Kamal Therapeutics, Inc.
Kamal Therapeutics, Inc.: Form D filings
Kamal Therapeutics, Inc., a pharmaceuticals company in Hingham, MA, filed 3 Form D notices with the SEC between 2021 and 2025. The latest, on November 24, 2025, reports $13.8 million sold of a $17.3 million offering to 41 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 66 CLUBHOUSE DRIVE, Hingham, MA, 02043
- Phone
- (857) 222-4653
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2020
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1880064
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Nov 24, 2025 | New notice | $17,307,138 | $13,807,138 | $3,500,000 | 41 | Nov 10, 2025 | sec.gov |
| Oct 11, 2022 | Amendment | $10,000,000 | $9,943,000 | $57,000 | 37 | Aug 18, 2021 | sec.gov |
| Aug 27, 2021 | New notice | $10,000,000 | $4,317,000 | $5,683,000 | 25 | Aug 18, 2021 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Mark de Souza | Executive Officer, Director | |
| Philip Reilly | Director | |
| John Parker | Director |
Other pharmaceuticals companies in Massachusetts that filed recently
- Land Therapeutics Inc. $17.5 million · Oct 21, 2026
- Crosslink Therapeutics Inc. $5.5 million · Oct 20, 2026
- Sentonix, Inc. $12.7 million · Aug 20, 2026
Every Form D from the week of Nov 24, 2025 · All recent filings in Massachusetts · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Kamal Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.